Literature DB >> 17942126

Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet.

Zhi-yuan Fang1, Rong Lin, Bing-xiang Yuan, Yu Liu, Hui Zhang.   

Abstract

Tanshinone IIA (Tan IIA) is one of the major lipophilic components of Salvia miltiorrhiza Bunge (SM) and has an anti-atherosclerotic effect. To investigate the potential mechanism of this effect, we established an atherosclerotic animal model by feeding rabbits a high-fat diet, and Tan IIA was given at different doses. Intimal area of the aorta was measured by image analysis, serum levels of vascular adhesion molecule-1 (VCAM-1) and interleukin (IL-1beta) were measured by ELISA, while matrix metalloproteinase-2 and-9 (MMP-2, MMP-9) expression and their activities in atherosclerotic lesions were assessed by Western blotting and zymography respectively. Compared with the control group, the intimal area, serum levels of VCAM-1 and IL-1beta, the expression of MMP-2 and MMP-9 as well as their activities were increased significantly in the high-fat fed rabbit group. After Tan IIA administration, all of these parameters were decreased in a dose-dependent manner. Our results show that Tan IIA can inhibit atherosclerotic lesion formation in aorta and down-regulate protein expression and activities of MMP-2 and MMP-9 as well as serum VCAM-1 and IL-1beta in rabbits fed a high-fat diet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942126     DOI: 10.1016/j.lfs.2007.08.043

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells.

Authors:  Weirong Wang; Ling Bai; Hu Qiao; Yanxiang Lu; Lina Yang; Jiye Zhang; Rong Lin; Feng Ren; Jianfeng Zhang; Meixi Ji
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Sodium tanshinone IIA silate as an add-on therapy in patients with unstable angina pectoris.

Authors:  Haiyan Zhang; Mingzhi Long; Zhiwen Wu; Xu Han; Yichao Yu
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

3.  Tanshinone IIA Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Infected with Porphyromonas gingivalis.

Authors:  Yan Xuan; Yue Gao; Hao Huang; Xiaoxuan Wang; Yu Cai; Qing Xian Luan
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

4.  Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction.

Authors:  Tsai-Hui Lin; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2010-06-21       Impact factor: 5.455

Review 5.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

6.  Tanshinone IIA: A Promising Natural Cardioprotective Agent.

Authors:  Qinghua Shang; Hao Xu; Li Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-06       Impact factor: 2.629

Review 7.  Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis.

Authors:  Zhuo Chen; Hao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-02       Impact factor: 2.629

8.  Effects of Salvia miltiorrhiza ethanolic extract on lipopolysaccharide-induced dental alveolar bone resorption in rats.

Authors:  Huang-Tzu Tsai; Wen-Liang Chang; Hsiao-Pei Tu; Earl Fu; Yao-Dung Hsieh; Cheng-Yang Chiang
Journal:  J Dent Sci       Date:  2015-09-09       Impact factor: 2.080

9.  Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase.

Authors:  Wen-yu Wu; Hong Yan; Xin-bo Wang; Yu-zhou Gui; Fei Gao; Xi-lan Tang; Yin-lin Qin; Mei Su; Tao Chen; Yi-ping Wang
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

10.  Natural plant products in treatment of pulmonary arterial hypertension.

Authors:  Lili Xiang; Ying Li; Xu Deng; Djuro Kosanovic; Ralph Theo Schermuly; Xiaohui Li
Journal:  Pulm Circ       Date:  2018-06-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.